Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study

The aim of the present study was to determine the effects of luseogliflozin on 24‐h glucose levels, assessed by continuous glucose monitoring, and on pharmacodynamic variables measured throughout the day. In this double‐blind, placebo‐controlled, crossover study, 37 patients with type 2 diabetes mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032984/
https://www.ncbi.nlm.nih.gov/pubmed/25930989
http://dx.doi.org/10.1111/dom.12481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032984/
https://www.ncbi.nlm.nih.gov/pubmed/25930989
http://dx.doi.org/10.1111/dom.12481

Ejemplares similares